Knight Therapeutics Inc T.GUD

Alternate Symbol(s): KHTRF

Healthcare

Knight Therapeutics Inc. is a Canada-based specialty pharmaceutical company. The Company's principal business activity includes developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invested in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The Company's portfolio consists of pharmaceutical products with molecules and includes both in-licensed products, such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome as well as products owned (or partially owned) by it, such as Exelon and Impavido.

TSX:GUD - Post by User

Knight Therapeutics Inc > New NCIB in place on the 14th

<< Previous

Bullboard Posts

Next >>

Post by EbbFlow88on Jul 12, 2022 8:22am

266 Views

Post# 34817367

New NCIB in place on the 14th

So, as of June 30th we now have 114.6M shares outstanding. 79.9M of which are public float. On thursday, we can now buy up to 7.99M shares.

As Mugsy has mentioned before as well as a few others, the float is getting tighter and tighter as savvy allocators are picking up cheap shares. Just a matter of time.

<< Previous

Bullboard Posts

Next >>

A junior copper-gold stock trading at a bargain of monumental proportions